Edition:
United States

People: GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,549.50GBp
9:31am EDT
Change (% chg)

-9.00 (-0.58%)
Prev Close
1,558.50
Open
1,556.00
Day's High
1,557.00
Day's Low
1,544.00
Volume
3,662,119
Avg. Vol
8,621,727
52-wk High
1,745.56
52-wk Low
1,363.00

Troy, Daniel 

Mr. Daniel Troy is Senior Vice President, General Counsel of GlaxoSmithKline PLC., since September 2008. He was previously a Partner at the Washington law firm Sidley Austin LLP, where he represented mainly pharmaceutical companies and trade associations on matters related to the US Food and Drug Administration (FDA) and government regulations. Dan was formerly Chief Counsel for the FDA, where he served as a primary liaison to the White House and the US Department of Health and Human Services. Dan is a graduate from Cornell University’s School of Industrial and Labor Relations, and earned his law degree from Columbia University School of Law. Dan was named a ‘Legend in the Law’ at the Burton Awards.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --